Weekly insulin shots can help control both Type 1 and Type 2 diabetes as well as daily injections do, a pair of clinical trials have found. Photo by Adobe Stock/HealthDay News Weekly insulin shots can ...

A once-weekly insulin formulation called icodec performed just as well as daily doses of the insulin degludec, Phase 3 clinical trial results show. Photo by peter-facebook/Pixabay People with Type 2 ...

A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ...

An international study co-led by University of Calgary researchers has found new insulin delivery technology helps control ...

Every time Kelly publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

Insulin icodec, a once-weekly basal injection to treat type 1 diabetes, has the potential to be as effective in managing the condition as daily basal insulin treatments, according to research from the ...

A breakthrough in Type 1 diabetes treatment shows promise. Scientists in Sweden have successfully transplanted gene-edited ...

Dr. Saudek answers the question: 'What Is Insulin & Why Is It Needed?' — -- Question: What is insulin and why do some diabetics need to take it? Answer: Insulin is a hormone. It's made by certain ...

People with diabetes have more than a few hassles, particularly at meals. They not only have to measure their blood glucose levels and inject the right amount of insulin, but carry all the relevant ...

Eli Lilly is continuing to work to lower the out-of-pocket costs for people using insulin. The company announced that it is lowering the list price of Insulin Lispro Injection by an additional 40% ...

Tests in animals show the material works like the body's own system. Post content hidden for low score. Show… Post content hidden for low score. Show… Seems like a pretty interesting idea. I know a ...

Data were obtained through an Internet survey of U.S. adults self-identified as taking insulin to treat type 1 or type 2 diabetes; the survey was conducted 13 June to 7 July 2008 by Harris Interactive ...